Virological Approach - Assembly and Secretion Inhibitors | Tim Block, PhD

International Workshop on HBV Cure 2016

Update on DDI guidelines of the FDA - in vitro | Xinning Yang, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Clinical Pharmacology of Integrase Inhibitors | Giovanni Di Perri, MD, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Last advances in HIV pharmacogenomics | Andrea Calcagno, MD, DTM&H

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

How/when will pharmacogenomics translate into improved clinical care? | David Haas, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Application of Physiologically based pharmacokinetic (PBPK) Modelling to Drug Development Decisions | Joga Gobburu, PhD, MBA

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

The use of DAA’s in pregnancy in HCV infected mothers | David Burger, PharmD, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Viral Dynamics and the Search for an HIV Cure | Stephen Becker, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Clinical Development of Long-Acting Broadly Neutralizing Monoclonal Antibodies: Lessons Learned Thus Far | Richard Koup, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

How to End the Global HCV Epidemic - the role of injectables | David Thomas, MD, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Debate: Can we eliminate HCV from Africa? | Mark Nelson, MD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

Debate: Can we eliminate HCV from Africa? | Richard Njouom, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

The new epidemic of drug resistant HIV-1 | Gillian Hunt, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

ALERRT - The African coaLition for Epidemic Research, Response and Training | Peter Horby, MD, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

PANDORA-ID-NET | Francine Ntoumi, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

Rise and spread of multi-drug resistant malaria | Francine Ntoumi, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

Innovation in surveillance / early warning systems | Mah-Sere Keita, MPH

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

Genomics for tracing the cholera epidemic in Africa | Francois-Xavier Weill, MD, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

The role of the human/animal interface in the zoonoses | Jean-Jacques Muyembe, MD, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

Fast-tracking vaccines for epidemic diseases: An update from CEPI | Richard Hatchett, MD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

HAV in a Tertiary Hospital: 2017 Epidemic vs 2009-2016 Period | Andrea Lombardi, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective | Luz Martin-Carbonero, MD, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective | Massimo Puoti, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

NAFLD in HIV- infected patients | Juan Macías, MD, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018